- $4.73bn
- $3.69bn
- CNY22.53bn
- 71
- 42
- 41
- 50
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 6,778 | 11,999 | 19,384 | 21,899 | 22,528 |
Cost of Revenue | |||||
Gross Profit | 1,190 | 2,840 | 4,043 | 3,849 | 5,442 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 8,273 | 15,140 | 25,813 | 28,939 | 27,579 |
Operating Profit | -1,495 | -3,141 | -6,429 | -7,039 | -5,051 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -1,268 | -3,001 | -6,713 | -7,404 | -4,733 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1,304 | -3,054 | -6,809 | -7,508 | -4,812 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -1,289 | -3,012 | -6,789 | -7,497 | -4,822 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1,289 | -3,012 | -6,789 | -7,497 | -4,822 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -3.99 | -8.71 | -17.9 | -19.7 | -11.7 |